NCT06256757View on ClinicalTrials.gov

Safety and Validity of Extracorporeal Fenestration and in Situ Fenestration in Patients With Aortic Disease Involving the Left Subclavian Artery

NANot yet recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 30, 2028

Study Completion Date

April 30, 2029

Conditions
Aortic Dissection Aneurysm
Interventions
PROCEDURE

fenestration

Thoracic EndoVascular Aortic Repair (TEVAR) with fenestrations

All Listed Sponsors
lead

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

NCT06256757 - Safety and Validity of Extracorporeal Fenestration and in Situ Fenestration in Patients With Aortic Disease Involving the Left Subclavian Artery | Biotech Hunter | Biotech Hunter